Ordering
Available Variants5 mg
CHA.75721-5mg
Price
€161.60
Available – Dispatch in 14 days
25 mg
CHA.75721-25mg
Price
€484.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.75721-5mg | €161.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.75721-25mg | €484.80 |
≥97% (NMR), solid
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C8H20NO4P · xH2O |
|---|---|
| CAS Number | 123690-79-9 |
| Molecular Weight | 225.22 (anhydrous basis) |
| NACRES | NA.77 |
| PubChem Substance ID | 329775103 |
| UNSPSC Code | 12352200 |
| MDL number | MFCD11045877 |
| Assay | ≥97% (NMR) |
| Form | solid |
| Quality level | 100 |
| Storage condition | desiccated |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
CGP 35348 hydrate, with a CAS number of 123690-79-9, is a synthetic compound that has been investigated for its potential therapeutic applications. This substance is a GABA_B receptor antagonist, which means it acts by blocking the action of the neurotransmitter gamma-aminobutyric acid (GABA) at its receptor sites. By inhibiting the activity of GABA, CGP 35348 hydrate can modulate neuronal excitability and synaptic transmission, leading to various physiological effects. Research has explored its possible uses in treating conditions such as anxiety, epilepsy, and other neurological disorders. The hydrate form of CGP 35348 is notable for its stability and solubility, making it a useful tool for scientific studies and potential pharmaceutical development. Further investigation is needed to fully understand the mechanisms and potential benefits of CGP 35348 hydrate.
